{
    "eid": "2-s2.0-85147693602",
    "title": "Comparison of the Immune Response After an Extended Primary Series of COVID-19 Vaccination in Kidney Transplant Recipients Receiving Standard Versus Mycophenolic Acid-sparing Immunosuppressive Regimen",
    "cover-date": "2022-10-25",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Transplantation",
            "@code": "2747",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [],
    "authors": [
        "Supitchaya Phirom",
        "Jeerath Phannajit",
        "Watsamon Jantarabenjakul",
        "Leilani Paitoonpong",
        "Thidarat Kitrungphaiboon",
        "Nuchjarnun Choktaweesak",
        "Pawinee Kupatawintu",
        "Salin Wattanatorn",
        "Wisit Prasithsirikul",
        "Somchai Eiam-Ong",
        "Yingyos Avihingsanon",
        "Pokrath Hansasuta",
        "Jakapat Vanichanan",
        "Natavudh Townamchai"
    ],
    "citedby-count": 1,
    "ref-count": 41,
    "ref-list": [
        "COVID-19-related mortality in kidney transplant and dialysis patients: Results of the ERACODA collaboration",
        "Results from the ERAEDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe",
        "Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: National prospective cohort study",
        "COVID-19 infection in kidney transplant recipients",
        "Efficacy of covid-19 vaccines in immunocompromised patients: Systematic review and meta-analysis",
        "Cellular and humoral response after MRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients",
        "Safety of everolimus with reduced calcineurin inhibitor exposure in De Novo kidney transplants: An analysis from the randomized TRANSFORM study",
        "Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus",
        "SARS-CoV-2-specific humoral and cell-mediated immune responses after immunization with inactivated COVID-19 vaccine in kidney transplant recipients (CVIM 1 study)",
        "Comparison of the immunogenicity of ChAdOx1 nCoV-19 vaccine against the wild-type and delta variants in kidney transplant recipients and healthy volunteers",
        "Immunogenicity of SARS-CoV-2 BNT162b2 vaccine in solid organ transplant recipients",
        "Safety and immunogenicity of anti-SARS-CoV-2 messenger RNA vaccines in recipients of solid organ transplants",
        "Efficacy and safety of third dose of the COVID-19 vaccine among solid organ transplant recipients: A systemic review and meta-analysis",
        "The type of SARS-CoV-2 vaccine influences serological response in kidney transplant recipients",
        "Randomized trial of a third dose of mRNA-1273 vaccine in transplant recipients",
        "Improved immunogenicity against SARS-CoV-2 in a solid-organ transplant recipient by switching vaccines",
        "Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination",
        "Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination",
        "Observations on improving COVID-19 vaccination responses in kidney transplant recipients: Heterologous vaccination and immunosuppression modulation",
        "Intensity of mycophenolate mofetil treatment is associated with an impaired immune response to SARS-CoV-2 vaccination in kidney transplant recipients",
        "Immunogenicity of a single dose of SARS-CoV-2 messenger RNA vaccine in solid organ transplant recipients",
        "Antibody response after a third dose of the mRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients with minimal serologic response to 2 doses",
        "Antibody response to SARSCoV-2 mRNA vaccine among kidney transplant recipients: A prospective cohort study",
        "Serological response to three, four and five doses of SARS-CoV-2 vaccine in kidney transplant recipients",
        "De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients",
        "Influenza immunization and the generation of anti-HLA and anti-MICA antibodies in patients with renal failure and in kidney transplant recipients",
        "SARS Cov-2 vaccination induces de novo donor-specific HLA antibodies in a renal transplant patient on waiting list: A case report",
        "Safety and immunogenicity of two RNA-based covid-19 vaccine candidates",
        "A randomized controlled trial of comparative effectiveness between the 2 dose and 3 dose regimens of hepatitis a vaccine in kidney transplant recipients",
        "A third injection of the BNT162b2 mRNA COVID-19 vaccine in kidney transplant recipients improves the humoral immune response",
        "Efficiency of a boost with a third dose of anti-SARS-CoV-2 messenger RNA-based vaccines in solid organ transplant recipients",
        "Cellular immunity predominates over humoral immunity after homologous and heterologous mRNA and vector-based COVID-19 vaccine regimens in solid organ transplant recipients",
        "Enhanced SARSCoV-2 antibody response after a third heterologous vector vaccine Ad26COVS1 dose in mRNA vaccine-primed kidney transplant recipients",
        "Three doses of an mRNA Covid-19 vaccine in solid-organ transplant recipients",
        "Safety and cross-variant immunogenicity of a three-dose COVID-19 mRNA vaccine regimen in kidney transplant recipients",
        "MTOR inhibitors improve both humoral and cellular response to SARS-CoV-2 messenger RNA BNT16b2 vaccine in kidney transplant recipients",
        "Enhanced humoral immune response after COVID-19 vaccination in elderly kidney transplant recipients on everolimus versus mycophenolate mofetil-containing immunosuppressive regimens",
        "Absolute lymphocyte count predicts the response to new influenza virus H1N1 vaccination in pediatric cancer patients",
        "An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients",
        "Safety of everolimus with reduced calcineurin inhibitor exposure in de novo kidney transplants: An analysis from the randomized TRANSFORM Study: Erratum",
        "Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60031780",
            "affilname": "Thai Red Cross Agency",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031780",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nontaburi",
            "@id": "60021173",
            "affilname": "Bamrasnaradura Infectious Disease Institute",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021173",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "112812049",
            "affilname": "Bhumirajanagarindra Kidney Institute",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/112812049",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Ratchadapisek Sompoch Endowment Fund",
        "Chulalongkorn University"
    ]
}